AbCellera Biologics Inc (ABCL) (Q3 2026) Earnings Call Highlights: Breakthrough Hot Flash Data ...
AbCellera Biologics Inc (ABCL) posted a narrower quarterly loss, showcased Phase 2 results for ABCL635 that rival hormone therapy, and ended the quarter with over $890 million in available liquidity. Related Stocks: ABCL ,